<DOC>
	<DOCNO>NCT00176839</DOCNO>
	<brief_summary>This protocol use busulfan , cyclophosphamide melphalan design condition therapy patient receive stem cell transplantation acute leukemia myelodysplastic syndrome ( MDS ) . The hypothesis new regimen well tolerated cure patient .</brief_summary>
	<brief_title>Stem Cell Transplantation Hematological Malignancies</brief_title>
	<detailed_description>Subjects admit bone marrow transplant unit put isolation reduce exposure infectious agent . Prior transplantation , receive BUSULFAN via central venous line , four time day four day , CYCLOPHOSPHAMIDE via central venous line day two day , MELPHALAN via central venous line one day . Busulfan , cyclophosphamide , melphalan give destroy subject 's cancer . As well , drug destroy immune system help ensure new stem cell take grow transplantation . On day transplantation , umbilical cord blood donor transfuse via venous line . These new cell replace subject 's bone marrow . After transplantation , subject receive Cyclosporin A either MMF MTX Isolation continue adequate number cell present blood fight infection . Subjects discharge hospital medically ready . They expect return follow-up blood marrow transplant clinic specific date determine physician .</detailed_description>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Patients must diagnosis acute lymphocytic leukemia ( ALL ) , acute myeloid leukemia ( AML ) myelodysplastic syndrome ( MDS ) currently complete remission . Patients must either : &lt; 18 year age least 6 month initial hematopoietic cell transplant ( HCT ) , 1935 year age least 18 month initial HCT , &lt; 35 year age receive sufficient radiation treatment ineligible total body irradiation ( TBI ) contain preparative therapy Adequate major organ function include : Cardiac : ejection fraction &gt; = 45 % Renal : creatinine clearance &gt; = 40 mL/min Hepatic : clinical evidence hepatic failure ( e.g . coagulopathy , ascites ) Karnofsky performance status &gt; = 70 % Lansky score &gt; = 50 % Women child bear age must use adequate birth control negative pregnancy test . Written informed consent . Eligible TBI contain preparative regimen . Active uncontrolled infection within one week HCT . Pregnant lactate female .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Stem Cell transplant</keyword>
	<keyword>retransplant</keyword>
	<keyword>hematological malignancy</keyword>
</DOC>